Swissmedic is introducing the possibility of sending questions on the Restricted Part of the application documentation directly to the Drug Master File (DMF) holder in encrypted form via IncaMail¹.
The authorisation holder and the DMF holder can now give their agreement to this delivery method in the “Form DMF”. Delivery by post, as previously, remains an option.
The revised “Form DMF” is valid with effect from 1 November 2026.